InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,528.75
(
0.06%
)
US TECH 100
18,898.00
(
-0.02%
)
Dow Jones
40,227.59
(
0.28%
)
Brent Oil
64.64
(
0.11%
)
Bitcoin
95,004.61
(
0.02%
)
Post# of 123427
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

researcher59

Send PM Follow Ignore
Followers 326
Posts 32920
Boards Moderated 22
Alias Born 12/30/2004

researcher59

Member Level

Re: valuemind post# 120315

Tuesday, 03/25/2025 11:18:40 AM

Tuesday, March 25, 2025 11:18:40 AM

Post# of 123427
CRMD -3.38 to 7.39 after reporting strong Q4 results but disappointing revenue guidance -

briefing -

Cormedix beats by $0.09, beats on revs (10.77 ) :
Reports Q4 (Dec) earnings of $0.22 per share, excluding non-recurring items, $0.09 better than the FactSet Consensus of $0.13; revenues rose 29900.0% year/year to $30 mln vs the $27.28 mln FactSet Consensus.
CorMedix is announcing preliminary net revenue guidance for first half of 2025 of $50 -- $60 million, based on the run rate of current purchasing customers, with more than $33 million expected in first quarter. In addition, the Company reiterates its previously announced cash operating expense guidance for 2025 of $72 -- $78 million.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up